BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/20/2017 4:03:35 AM | Browse: 1139 | Download: 2177
 |
Received |
|
2017-07-26 01:13 |
|
Peer-Review Started |
|
2017-07-26 13:14 |
|
To Make the First Decision |
|
2017-08-10 00:28 |
|
Return for Revision |
|
2017-08-15 00:30 |
|
Revised |
|
2017-08-28 17:09 |
|
Second Decision |
|
2017-09-07 00:08 |
|
Accepted by Journal Editor-in-Chief |
|
2017-09-07 00:22 |
|
Accepted by Executive Editor-in-Chief |
|
2017-09-13 02:58 |
|
Articles in Press |
|
2017-09-13 02:58 |
|
Publication Fee Transferred |
|
2017-09-29 13:50 |
|
Edit the Manuscript by Language Editor |
|
2017-11-06 09:23 |
|
Typeset the Manuscript |
|
2017-11-13 01:40 |
|
Publish the Manuscript Online |
|
2017-11-20 04:03 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/ licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Retrospective Study |
| Article Title |
Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Lin Wang, Yan Hong, Jie Wu, Ying-Kit Leung and Ying Huang |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Medical Science and Technology Planning Project of Zhejiang Province, China |
2015KYB430 |
|
| Corresponding Author |
Ying Huang, MD, PhD, Professor, Department of Gastroenterology, Pediatric Inflammatory Bowel Disease Research Center, Children’s Hospital of Fudan University, No. 399 Wanyuan Road, Minhang District, Shanghai 201102, China. yhuang815@163.com |
| Key Words |
Inflammatory bowel disease; Intestinal tuberculosis; Anti- tubercular treatment; Thalidomide; Children |
| Core Tip |
Therapies for Crohn’s disease (CD) and intestinal tuberculosis are totally different, and anti-TNF alpha treatment may increase the risk of tuberculosis reactivation. That makes it still tough to treat patients with severe CD with concomitant tuberculosis, especially in high tuberculosis prevalence areas. In the current study, all patients had evidence of tuberculosis infection and diagnosed with CD. Thalidomide yielded a positive result for those special cases, and it could be an alternative drug after treatment of tuberculosis is completed. |
| Publish Date |
2017-11-20 04:03 |
| Citation |
Wang L, Hong Y, Wu J, Leung YK, Huang Y. Efficacy of thalidomide therapy in pediatric Crohn’s disease with evidence of tuberculosis. World J Gastroenterol 2017; 23(43): 7727-7734 |
| URL |
http://www.wjgnet.com/1007-9327/full/v23/i43/7727.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i43.7727 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
